Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Thanks for clearing that up PL and Ice, appreciate the response. 👍
Greening, ignore Bella, she think it’s one vote per shareholder. She’s talking about a lad scrawling lines on a whiteboard on a blog presentation.
https://www.turnerpope.com/wp-content/uploads/2024/04/2.AvactaGroupplc_29-2-2024_FINAL_BGv2.pdf
See page 6. Expecting commercialisation in 2026 following phase 2 which is registrational for their chosen indication. Phase 3 will take place beyond then, likely with partners for global markets, and for other indications.
PS that white board on that video was explaining the general approval process for Avacta drug pipeline . Not individual drug candidates which will be analysed on a case by case basis, depending on the supporting evidence within the clinical trial.
Bella commercial 2026 according to the investment note. My point was the FDA will make a decision based on the emerging data sometime in the future. Could be phase 3 could be in the middle of phase 2 could even be approved by surrogate endpoint. What’s important is the FDA will make a decision though that’s inevitable. All we need to do is wait for the results and hopefully they will be positive.
Hi Bella, did it show P3 along AVA6000 line or along the line of the others? I watched the video but didn't spot it.
Cheers
Icecool...'AVA6000 will get approved when it’s ready to get approved, you might be beholden to a timeline,'
On the presentation board in the latest CC video it shows approval after P3...???!!
“Ice, really, Its you that are so sure about everything. I am forever saying we don't know Jack.”
Windy why are you here???, my strategy pretty straightforward wait for FDA approval, what I can’t understand is if you don’t believe in my strategy, which let’s be honest the vast majority of LTH’s believe in my strategy, what’s the alternative, what do you want to achieve here on this BB? I really don’t understand why you bother if you don’t believe FDA approval will happen and it will be the catalyst for success, you are better off in other companies like CHAR. Also don’t worry about me, I bought way more at 43.5 and usually buy when it’s on sale my average is reducing all the time, however that’s not something that concerns me because, on FDA approval this will blast past ATH’s imo so anyone that bought at any time, will still be quids in. 👍😊
Sheppy aka wynbore yes 68p. That will be £6.80. Plus in a few years. Your are such a muppet.
"You really are an idiot sometimes, "
Ice, really, Its you that are so sure about everything. I am forever saying we don't know Jack.
What i try to see if is there any cause and effect.
I see more cohorts and dosing which AVCT says were an unexpected surprise, delaying the trail but about 12-15 months. This then caused another raise.
I see thanks to hurst, every tom dick and harry being bought out for billions on what at face value seems a tiny fraction of AVCT's value, so i come to the conclusion that BP are not interested (for whatever reason), and in the meantime the 3 raises that have come in at 120p, 95p and now 50p causing ever more dilution and capital destruction as a company that is running a trial that has so far not gone to their plan.
You on the other hand see 3 years of SP decline as micro BS and keep saying when FDA approval comes etc etc as though its nailed on.
If it were already done, it would already be approved.
Yet I am the short term gambler and you are the long term.... (use any adjective that comes to mind to make you feel better.
(And not for nothing but my last purchase of last week is up 10%, you may think thats peanuts but its a start, let me know when you get to breakeven, admittedly my purchase was based on the voodoo of charts, but who cares. I could have bought a load at 50p instead, although at the time I said I wouldn't due to the voodoo thing again.)
Me too cj62, the Newcastle and Blades bit. Not as confident on the ‘speculation’ part.
Did you not call Wyndrum an idiot? You really are something else
Thanks Sheppy I feel flattered a multi millionaire would take time to call me an idiot on an investment forum. Truly privileged!! 😊😊💯
I think you are the idiot Ice
Are you on Avacta board meetings? You don’t have a clue what is going on??? You make huge hypothetical assumptions everyday, what contact has been made by BP we don’t have a clue what discussions have been done etc also Avacta obviously don’t care about the share price they were wanting institutional representation at all costs why is that? Maybe they wanted to protect any hostile takeover at the voting stage……. You really are an idiot sometimes, I still don’t think you are invested as well tbh.
Wyndrum they are not ‘right bright’ to use a Yorkshire expression!
"They are also building a platform of chemo drugs, I’m sure they probably could have rushed AVA6000 after cohort 4 however the fact they didn’t find an MTD and got valuable information will help the clinical process of other drug candidates AVA3996."
Your sure.. probably... yet no other pahrma can see it or has seen it yet, although AVCT have moved to London to be next door to BP and all the other "likes" from other players in the field, and the science day and the posters that have been displayed and the RNS's (which always move the SP so someone is reading, but not apparently people as smart as you to figure it out.
Buth this was the best one...."Maybe Avacta are not for sale this raise was to protect any hostile takeover attempts."
Ha ha ha, My house is not for sale so I am going to reduce the price by 50% to put people off from trying to buy it.....
Do you not, when you are writing out your reply realise how desperate it sounds?
Some hypothetical scenarios below.
Maybe Avacta are not for sale this raise was to protect any hostile takeover attempts.
Alternatively a price has already been agreed on condition of positive results in phase 2. That would explain why they don’t give a toss about current share price. If they have provisionally agreed a price on positive data, today’s price is irrelevant.
They are also building a platform of chemo drugs, I’m sure they probably could have rushed AVA6000 after cohort 4 however the fact they didn’t find an MTD and got valuable information will help the clinical process of other drug candidates AVA3996.
AVA6000 will get approved when it’s ready to get approved, you might be beholden to a timeline, I am happy to wait for the inevitable conclusion no matter how long it takes. (it will conclude and a decision will be made one way or another as data emerges) The prize on offer of approval of AVA6000 will be worth the wait in the long run, if you believe it will happen.
Good luck to you sheppy / I’m in Dubai currently by a pool looking at the Burj Khalifa & I’m travelling round the south of France for a month in a couple of weeks time - no permanent oversea residences for me but I’m happy staying in Avacta! 🥂 and certainly hope the shorters here get burned next week GL
Says Watching the biggest clown of the lot!
I’m in at 68 p how good am I and how clever am I? Oh yes just realised the share price is 43 p and I’m losing money. Mmm
A real clown!
The thing is Ice, when?
|You keep saying Micro this Macro that, as though somehow that is an argument that trumps all others, but other small oncology companies are as you say, being bought out, so why hasn't AVCT?
The science worked clearly (from our pov) after cohort 3, or 4 to be absolutely sure. Why then another 3 to go up to 7? wasn't it only to emphasize how fantastic it was?
Is that what you believe? Or do you accept that after dose 4 it was not unequivocal that it worked and that more dosing was required?
Because it seems to me, if it "works" in the way that you are so absolutely convinced by and its just a matter of time, then AVCT should have been bought out already but if more proof were needed then it means clearly, the data was not as one sided as we all were led to believe?
Which one is it?
The shortin* fud team seen to uneasy today. lol.its Burn time !
Sheppy's become wyndrone but with extra powers. Have you found the million you lost yet sheppy ?
Three clowns in a line on a thread ! Do I win a prize 😄
You all need to do some research on how much FDA oncology drugs are worth then re-evaluate the micro thinking, that further potential dilution will have any great impact on the investment case here. The Mkt cap here is only 175 million odd. Oncology drugs go into the billions not to mention full validation of platform. The science is exceptional, actually they say clearly proof of concept has been achieved. The sample size while small at the moment has been backed by 10+ biopsy data and nothing in the science says we won’t see efficacy in high fap dox sensitive tumours. So sheppy nothing in the science then just small sample size and yet to prove efficacy on paper how very boring 🥱. An FDA approval decision will happen inevitably. If positive that will be the catalyst for success here.
Well it looks to me that the operators that create FUD to aid short selling are looking very worried here 🤣😂🤣😂🤣😂😜😎😎😎🥳🥳🥳
I think they will get burnt properly for once at last!!